Clinical Trial

Myeloproliferative Neoplastic Diseases Observatory From Brest

Study acronym: OBENE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2024 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
All patients diagnosed or followed in Brest University Hospital for Philadelphia negative myeloproliferative neoplasms will be included in this observational study. Myeloproliferative neoplasms recorded included: polycythemia vera, essential Thrombocythemia and Primary Myelofibrosis. This is a not interventional study. Alive patients need to sign a non-opposition consent form. Patients will be followed until last news (death, change of reference centre...).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2016-09-07; most recent amendment 2024-08-09.
Trial Details
NCT Number NCT02897297
Lead Sponsor University Hospital, Brest
Conditions Polycythemia Vera, Essential Thrombocythemia, Primary Myelofibrosis
Enrollment 1,000 participants
Start Date 2015-09-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-12